Guobin Wu

1.4k citations

35 papers · 909 indexed · h-index 16

Impact in

Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in ⓘ

Hepatology 15
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Liver Disease and Transplantation 4
Molecular Biology 13
- RNA modifications and cancer 6

Co-authors: Mengchao Wu (4 shared papers)Jian Zhao (4 shared papers)Rongyun Mai (9 shared papers)Anmin Liang (4 shared papers)Jiazhou Ye (14 shared papers)Bin Lü (3 shared papers)Yajun Guo (3 shared papers)Bin Lu (3 shared papers)
Journals: Gastroenterology (2 papers)BMC Cancer (2 papers)Therapeutics and Clinical Risk Management (2 papers)Hepatology (2 papers)Cancer Management and Research (2 papers)
Partner nations: China United Kingdom

In The Last Decade

Guobin Wu

33 papers receiving 894 citations

Peers

Countries citing papers authored by Guobin Wu

Since Specialization

Citations

This map shows the geographic impact of Guobin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wu more than expected).

Fields of papers citing papers by Guobin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wu. The network helps show where Guobin Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Guobin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guobin Wu Line = papers co-authored together Guobin Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Down-Regulation of Osteopontin Suppresses Growth and Metastasis of Hepatocellular Carcinoma Via Induction of Apoptosis Gastroenterology ·Jian Zhao, Dong Li, Bin Lu, Guobin Wu, Dongmei Xu, Jingjing Chen, Kai Li, Xin Tong, Jianxin Dai, Side Yao, Mengchao Wu, Yajun Guo	2008	116
2	Epigenetic Silence of Ankyrin-Repeat–Containing, Sh3-Domain–Containing, and Proline-Rich-Region– Containing Protein 1 ( Aspp1 ) and Aspp2 Genes Promotes Tumor Growth in Hepatitis B Virus–Positive Hepatocellular Carcinoma Hepatology ·Jian Zhao, Guobin Wu, Fangfang Bu, Bin Lü, Anmin Liang, Lei Cao, Xin Tong, Xin Lü, Mengchao Wu, Yajun Guo	2009	92
3	miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients Oncology Reports ·Chao‐Yuan Huang, Xinping Huang, Jiye Zhu, Zhigang Chen, XIAN-JIAN LI, Xuehui Zhang, Shan Huang, Jianbo He, Fang Lian, Zhao Yin-nong, Guobin Wu	2015	73
4	TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of p53 Messenger RNA in Human Hepatocellular Carcinoma Cancer Research ·Jian Zhao, Jingjing Chen, Bin Lü, Li Dong, Huajing Wang, Chongshan Bi, Guobin Wu, Huaizu Guo, Mengchao Wu, Yajun Guo	2008	58
5	The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy Frontiers in Cellular and Infection Microbiology ·Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu	2021	57
6	Adjuvant therapy options following curative treatment of hepatocellular carcinoma: A systematic review of randomized trials European Journal of Surgical Oncology ·Jian‐Hong Zhong, Huangyi Li, L.-Q. Li, Xue‐Mei You, yuxin zhang, Yuan Zhao, J.-Y. Liu, Bang‐De Xiang, Guobin Wu	2012	57
7	Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma Oncotarget ·Jianbin Gu, Yong Li, Liqiao Fan, Qun Zhao, Bibo Tan, Kelei Hua, Guobin Wu	2017	46
8	Thirty‐kilodalton Tat‐interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma† Hepatology ·Jian Zhao, Bin Lu, Hao Xu, Xin Tong, Guobin Wu, Xia Zhang, Anmin Liang, Wen‐Ming Cong, Jianxin Dai, Hao Wang, Mengchao Wu, Yajun Guo	2008	45
9	Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma Surgery ·Rongyun Mai, Hua-ze Lu, Tao Bai, Rong Liang, Yan Lin, Liang Ma, Bang‐De Xiang, Guobin Wu, Le‐Qun Li, Jiazhou Ye	2020	42
10	<p>Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma</p> Cancer Management and Research ·Rongyun Mai, Jiazhou Ye, Zhongrong Long, Xianmao Shi, Tao Bai, Jie Chen, Le‐Qun Li, Guobin Wu, Feixiang Wu	2019	42
11	Increased Expression of iASPP, Regulated by Hepatitis B Virus X Protein-Mediated NF-κB Activation, in Hepatocellular Carcinoma Gastroenterology ·Bin Lu, Huaizu Guo, Jian Zhao, Chong Wang, Guobin Wu, Mingshu Pang, Xin Tong, Fangfang Bu, Anmin Liang, Sheng Hou, Xiaoyu Fan, Jianxin Dai, Hao Wang, Yajun Guo	2010	41
12	Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma Clinical Cancer Research ·Bin Lü, Yunchao Ma, Guobin Wu, Xin Tong, Huaizu Guo, Anmin Liang, Wen‐Ming Cong, Chang Liu, Hao Wang, Mengchao Wu, Jian Zhao, Yajun Guo	2008	39
13	<p>Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients</p> Cancer Management and Research ·Rongyun Mai, Yanyan Wang, Tao Bai, Jie Chen, Bang De Xiang, Guobin Wu, Feixiang Wu, Le‐Qun Li, Jiazhou Ye	2019	28
14	Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma Digestive Diseases and Sciences ·Jiye Zhu, Shan Huang, Guobin Wu, Chao‐Yuan Huang, XIAN-JIAN LI, Zhigang Chen, Lei Zhao, Zhao Yin-nong	2015	26
15	Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma BMC Cancer ·Min Wang, Shan Huang, Zefeng Chen, Zhiwei Han, Kezhi Li, Chuang Chen, Guobin Wu, Zhao Yin-nong	2020	20
16	c‐Myc‐mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma Cell Biology International ·Ning‐Fu Peng, Jindu Li, Jingrong He, Xianmao Shi, Hao Huang, Yishuai Mo, Ye Hang, Guobin Wu, Feixiang Wu, Bang‐De Xiang, Jian‐Hong Zhong, Le‐Qun Li, Shaoliang Zhu	2020	20
17	Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy BMC Gastroenterology ·Rongyun Mai, Tao Bai, Xiaoling Luo, Guobin Wu	2022	15
18	Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion BMC Cancer ·Rongyun Mai, Jie Zeng, Weida Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guobin Wu, Le‐Qun Li, Liang Ma, Jiazhou Ye, Tao Bai	2021	14
19	C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma Journal of Inflammation Research ·Rongyun Mai, Tingli Lu, Ri-Jin Lu, Can Zeng, Fang Lian, Le‐Qun Li, Guobin Wu, Jiazhou Ye	2024	10
20	Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma Journal of Gastrointestinal Surgery ·Rongyun Mai, Jie Zeng, Hua-ze Lu, Rong Liang, Yan Lin, Xuemin Piao, Xing Gao, Guobin Wu, Feixiang Wu, Liang Ma, Bang‐De Xiang, Le‐Qun Li, Jiazhou Ye	2020	9

About Guobin Wu

Guobin Wu is a scholar working on Hepatology, Molecular Biology, Oncology, Epidemiology and Cancer Research, having authored 35 papers that have together received 909 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (9 papers), RNA modifications and cancer (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related molecular mechanisms research (4 papers), Liver Disease and Transplantation (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Hepatology (254 citations), Cancer Research (270 citations), Epidemiology (249 citations), Oncology (184 citations) and Molecular Biology (448 citations). Guobin Wu has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Mengchao Wu, Jian Zhao, Rongyun Mai, Anmin Liang, Jiazhou Ye, Bin Lü, Yajun Guo, Bin Lu, Jianxin Dai and Yajun Guo. Their work appears in journals such as Gastroenterology, BMC Cancer, Therapeutics and Clinical Risk Management, Hepatology and Cancer Management and Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact